Oral Hydrogel Wound Dressing Market Share

  • Report ID: 4545
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Oral Hydrogel Wound Dressing Market Regional Analysis:

North American Market Insights

North America industry is likely to hold largest revenue share of 36% by 2035. The growth of the market in the region can be accounted for on the back of the rising prevalence of chronic wounds such as pressure ulcers, diabetic ulcers, and so on, coupled with rising healthcare expenditure. It became quite convenient for people to receive quick treatment since the developed health expenditure of multiple nations is providing the necessary workforce and medicines. As per the data provided by the Centers for Medicare & Medicaid Services, the national health expenditure of the United States is expected to rise by 5.1% per year between 2021 and 2030, reaching nearly USD 6.8 trillion. Moreover, the increasing occurrence of diabetic foot ulcers is another significant factor to drive the market growth as these dressings are very effective in diabetic foot ulcer treatment. Further, the presence of a strong healthcare network in the region, along with the availability of skilled medical professionals to use topical wound agents are also anticipated to contribute to the market growth in the region. In addition, the rising cases of chronic diseases, especially diabetes, are also expected to surge the growth of the North American market in the analysis period.

Oral Hydrogel Wound Dressing Market size-min

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of oral hydrogel wound dressing is estimated at USD 880.71 million.

The global oral hydrogel wound dressing market size was around USD 818.81 million in 2025 and is likely to expand at a CAGR of more than 8.4%, surpassing USD 1.83 billion revenue by 2035.

The North America oral hydrogel wound dressing market will secure around 36% share by 2035, driven by the rising prevalence of chronic wounds, increasing healthcare expenditure, and the growing number of chronic diseases like diabetes.

Key players in the market include Integra LifeSciences Corporation, Cardinal Health, Inc., Medline Industries, LP, Coloplast A/S, Smith & Nephew, AMERX Health Care Corp., B. Braun Melsungen AG, Mölnlycke Health Care AB, PAUL HARTMANN AG, DermaRite Industries, LLC,.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos